...
首页> 外文期刊>Photochemistry and Photobiology: An International Journal >Photodynamic effects of Zinc(II) phthalocyanine-loaded polymeric micelles in human nasopharynx KB carcinoma cells
【24h】

Photodynamic effects of Zinc(II) phthalocyanine-loaded polymeric micelles in human nasopharynx KB carcinoma cells

机译:载有锌(II)酞菁的聚合物胶束对人鼻咽KB癌细胞的光动力效应

获取原文
获取原文并翻译 | 示例
           

摘要

A major difficulty in photodynamic therapy is the poor solubility of the photosensitizer (PS) under physiological conditions which correlates with low bioavailability. PS aggregation leads to a decrease in the photodynamic efficiency and a more limited activity in vitro and in vivo. To improve the aqueous solubility and reduce the aggregation of 2,9(10),16(17),23(24)- tetrakis[(2-dimethylamino)ethylsulfanyl]phthal-ocyaninatozinc(II) (Pc9), the encapsulation into four poloxamine polymeric micelles (T304, T904, T1107 and T1307) displaying a broad spectrum of molecular weight and hydrophilic- lipophilic balance was investigated. The aqueous solubility of Pc9 was increased up to 30 times. Morphological evaluation showed the formation of Pc9-loaded spherical micelles in the nanosize range. UV/Vis and fluorescence studies indicated that Pc9 is less aggregated upon encapsulation in comparison with Pc9 in water-DMSO 2% and remained photostable. Pc9-loaded micelles generated singlet molecular oxygen in high yields. Photocytotoxicity assays using human nasopharynx KB carcinoma cells confirmed that the encapsulation of Pc9 in T1107 and T1307 increases its photocytotoxicity by 10 times in comparison with the free form in water-DMSO. In addition, Pc9 incorporated into cells was mainly localized in lysosomes. Zinc(II) phthalocyanine-loaded polymeric micelles generated singlet molecular oxygen in high yields. Photocytotoxicity assays using human nasopharynx KB carcinoma cells confirmed that the encapsulation of zinc(II) phthalocyanine in the polymeric micelles T1107 and T1307, increases its photocytotoxicity by 10 times in comparison with the free form in water-DMSO. A lysosomal localization was observed.
机译:光动力疗法的主要困难是光敏剂(PS)在生理条件下的溶解性差,这与低生物利用度有关。 PS聚集会导致光动力效率降低,并在体外和体内产生更有限的活性。为了提高水溶性,减少2,9(10),16(17),23(24)-四[[(2-二甲基氨基)乙基硫烷基]邻苯二甲酸氰基锌(II)(Pc9)的聚集,将其封装成四个研究了具有宽分子量和亲水亲脂平衡光谱的泊洛沙明聚合物胶束(T304,T904,T1107和T1307)。 Pc9的水溶性增加到30倍。形态学评估显示,在纳米范围内形成了装载Pc9的球形胶束。 UV / Vis和荧光研究表明,与水2%DMS​​O中的Pc9相比,封装后Pc9的聚集较少,并且仍保持光稳定性。装载Pc9的胶束以高产率产生单线态分子氧。使用人鼻咽KB癌细胞的光细胞毒性测定证实,与水-DMSO中的游离形式相比,在T1107和T1307中封装Pc9使其光细胞毒性增加了10倍。另外,掺入细胞的Pc9主要定位在溶酶体中。负载有酞菁锌的聚合胶束可高产率地产生单线态分子氧。使用人鼻咽KB癌细胞的光细胞毒性测定证实,在聚合物微团T1107和T1307中封装酞菁锌(II),与水-DMSO中的游离形式相比,其光细胞毒性增加了10倍。观察到溶酶体定位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号